Pyrazolo[1,5-A]pyrimidines as antiviral agents
US9278975B2 · kind B2 · utility
2Cited by
6References
1Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Dec 10, 2014 |
| Grant date | Mar 8, 2016 |
| Priority date | — |
| Expiry date | Dec 10, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/6561
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides compounds and pharmaceutically acceptable salts and esters and compositions thereof, for treating viral infections. The compounds and compositions are useful for treating Pneumovirinae virus infection including Human respiratory syncytial virus infections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.